Media Fill
Media Fill
Simulation
Process Simulation: Media Fill
Objective of media fill
To evaluate the capability of the aseptic process to produce
sterile drug product
To learn how failures have to be evaluated and what
consequences they have
All integral units (including units with cosmetic defects) should be incubated and
counted as part of media fill evaluation
Unit Inspection (container/closure defects)
Pre-incubation inspection: When a firm performs a
final production inspection of units immediately after
the media fill run, only those units found to be
defective in container/closure integrity can be
removed. Units with cosmetic defects should be
incubated and included as part of the media fill run.
Pharmaceutical regulations:
- Regulations: FDA “guidance for industry, sterile drug
products produced by aseptic processing – cGMP” -
- EU GMP Part I annex 1 –
- PIC/S PI 007-2 “recommendations on the validation of
aseptic process”
CONCLUSION
Even if all media fills are negative in a Company, it does
not necessarily indicate that no products were ever
possibly contaminated because the frequency
requirement of media fill testing is so minimal that it is
not statistically significant